Carol Moreno
Impact in
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 138
- Chronic Lymphocytic Leukemia Research 136
-
- Lymphoma Diagnosis and Treatment 73
- Co-authors
- Emili Montserrat (28 shared papers)Paolo Ghia (25 shared papers)Richard J. Roman (12 shared papers)Peter Hillmen (9 shared papers)Alessandra Tedeschi (16 shared papers)James P. Dean (14 shared papers)Thomas J. Kipps (13 shared papers)Paul M. Barr (13 shared papers)
- Journals
- Blood (41 papers)Physiological Genomics (8 papers)Leukemia (7 papers)Hypertension (7 papers)HemaSphere (7 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Carol Moreno
204 papers receiving 11.0k citations
Carol Moreno's Hit Papers
Peers
Comparison fields: 5 of 131
- Genetics 7.9k
- Pathology and Forensic Medicine 5.3k
- Hematology 1.8k
- Immunology 3.0k
- Gastroenterology 368
Countries citing papers authored by Carol Moreno
This map shows the geographic impact of Carol Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Moreno more than expected).
Fields of papers citing papers by Carol Moreno
This network shows the impact of papers produced by Carol Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Moreno. The network helps show where Carol Moreno may publish in the future.
Co-authors
The 25 scholars most cited alongside Carol Moreno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia Hit paper breakdown → | 2014 | 1374 |
| 2 | Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2018 | 469 |
| 3 | 2006 | 421 | |
| 4 | Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma Hit paper breakdown → | 2019 | 389 |
| 5 | Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study Hit paper breakdown → | 2019 | 385 |
| 6 | 2007 | 319 | |
| 7 | 2007 | 272 | |
| 8 | 2008 | 249 | |
| 9 | 2003 | 241 | |
| 10 | 2017 | 212 | |
| 11 | 2006 | 207 | |
| 12 | Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia Hit paper breakdown → | 2022 | 205 |
| 13 | 2019 | 194 | |
| 14 | 2015 | 189 | |
| 15 | 2015 | 187 | |
| 16 | 2021 | 180 | |
| 17 | Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort Hit paper breakdown → | 2022 | 176 |
| 18 | 2012 | 166 | |
| 19 | Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities Hit paper breakdown → | 2022 | 165 |
| 20 | 2014 | 159 |
About Carol Moreno
Carol Moreno is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Biochemistry, having authored 206 papers that have together received 11.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (136 papers), Lymphoma Diagnosis and Treatment (73 papers), Immunodeficiency and Autoimmune Disorders (52 papers), Renin-Angiotensin System Studies (19 papers), Chronic Myeloid Leukemia Treatments (16 papers), Hormonal Regulation and Hypertension (12 papers), Nitric Oxide and Endothelin Effects (12 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). The work is most often cited by research in Genetics (7.9k citations), Pathology and Forensic Medicine (5.3k citations), Hematology (1.8k citations), Immunology (3.0k citations) and Gastroenterology (368 citations). Carol Moreno has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Emili Montserrat, Paolo Ghia, Richard J. Roman, Peter Hillmen, Alessandra Tedeschi, James P. Dean, Thomas J. Kipps, Paul M. Barr, Howard J. Jacob and Jozef Lazar. Their work appears in journals such as Blood, Physiological Genomics, Leukemia, Hypertension and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.